Thiotepa Riemser Europäische Union - Deutsch - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastische mittel - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Flecainid HEXAL 100 mg Tabletten Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

flecainid hexal 100 mg tabletten

h e x a l aktiengesellschaft (3079284) - flecainidacetat - tablette - teil 1 - tablette; flecainidacetat (21899) 100 milligramm

Flecainid HEXAL 50 mg Tabletten Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

flecainid hexal 50 mg tabletten

h e x a l aktiengesellschaft (3079284) - flecainidacetat - tablette - teil 1 - tablette; flecainidacetat (21899) 50 milligramm

Arlevert 20 mg/40 mg Tabletten Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

arlevert 20 mg/40 mg tabletten

hennig arzneimittel gmbh & co kg - cinnarizin; dimenhydrinat - cinnarizin, kombination

Isemid Europäische Union - Deutsch - EMA (European Medicines Agency)

isemid

ceva santé animale - torasemide - high-ceiling-diuretika, sulfonamide, plain - hunde - für die behandlung der klinischen symptome im zusammenhang zu kongestiver herzinsuffizienz bei hunden, einschließlich lungenödem.